<DOC>
	<DOCNO>NCT00721448</DOCNO>
	<brief_summary>This single centre study conduct 3rd hospital affiliate Peking University . Approximately 24 healthy Chinese volunteer , male female , recruit obtain least 20 evaluable volunteer . The primary objective study characterize pharmacokinetics AZD6140 active metabolite AR-C124910XX single multiple ( twice daily ) dose AZD6140 90 mg 180 mg healthy Chinese volunteer . The secondary objective study determine safety tolerability single multiple ( twice daily ) 90 mg 180 mg dos AZD6140 physical examination , clinical laboratory test , vital sign , collection adverse event healthy Chinese volunteer .</brief_summary>
	<brief_title>An Open-Label , Single Multiple Dose Pharmacokinetic Study 90 mg 180 mg Doses AZD6140 Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Chinese ethnicity define parent 4 grandparent Chinese Have normal Body size weigh least 50 kg History diseases condition know interfere absorption , distribution , metabolism excretion drug determine investigator Current and/or past history intolerance hypersensitivity drug similar chemical structure mechanism action AZD6140 ingredient formulation Symptoms clinically significant illness within 2 week screen A personal family history bleed diatheses reasonable suspicion vascular abnormality include aneurysm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Pharmacokinetics</keyword>
</DOC>